Brief: Expres2ion Biotech Q4 Operating Income Falls To SEK 2.2 Mln
Feb 6 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* Q4 OPERATING INCOME: 2,178 (2,284) TSEK
* Q4 PROFIT/LOSS AFTER FINANCIAL ITEMS: -19,353 (-14,726)
TSEK
Source text: ID:nWkr6mG4YX
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations